Evidence map›Paper›PMID 29410158›Full record

ReviewAdvanced drug delivery reviews

Fluorescence anisotropy imaging in drug discovery.

Claudio Vinegoni, Paolo Fumene Feruglio, Ignacy Gryczynski, Ralph Mazitschek, Ralph Weissleder

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Plasmonic Amyloid Tactoids.Advanced materials (Deerfield Beach, Fla.) · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Two-Photon Fluorescence Imaging.Advances in experimental medicine and biology · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Near-Infrared-II Molecular Dyes for Cancer Imaging and Surgery.Advanced materials (Deerfield Beach, Fla.) · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudio VinegoniCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: cvinegoni@mgh.harvard.edu.
Paolo Fumene FeruglioCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Department of Neurological, Biomedical and Movement Sciences, University of Verona, Verona, Italy.
Ignacy GryczynskiUniversity of North Texas Health Science Center, Institute for Molecular Medicine, Fort Worth, TX, United States.
Ralph MazitschekCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Ralph WeisslederCenter for System Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.

Funding

TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI GOLAN, DAVID E. · 2014 to 2018
$10.8M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
Novel Clickdyes for Biomedical SensingR01EB010011 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2010 to 2017
$3.1M
Single Cell Imaging of the HeartR01HL122208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2014 to 2017
$1.7M
NCI NIH HHS T32 CA079443NHLBI NIH HHS R01 HL122208NIBIB NIH HHS R01 EB010011NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

Non-invasive measurement of drug-target engagement can provide critical insights in the molecular pharmacology of small molecule drugs. Fluorescence polarization/fluorescence anisotropy measurements are commonly employed in protein/cell screening assays. However, the expansion of such measurements to the in vivo setting has proven difficult until recently. With the advent of high-resolution fluorescence anisotropy microscopy it is now possible to perform kinetic measurements of intracellular drug distribution and target engagement in commonly used mouse models. In this review we discuss the background, current advances and future perspectives in intravital fluorescence anisotropy measurements to derive pharmacokinetic and pharmacodynamic measurements in single cells and whole organs.

Indexed as

Drug DiscoveryFluorescence PolarizationAnimalsHigh-Throughput Screening AssaysHumansDrug-target engagementFluorescence anisotropy imagingFluorescence polarization, fluorescence anisotropyFluorescently labeled drugsIntravital imagingSingle-cell pharmacodynamicsTwo photon microscopy

Identifiers

PMID29410158
PMCPMC6072632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.